VM Chart by TradingView

Business Description

Voyageur Pharmaceuticals Ltd., holder of three barium projects in B.C., including one with a resource estimate, and iodine properties in Utah, has a Joint Venture with privately held Chief Medical Supplies Ltd. (a Canadian pharmaceutical manufacturing and distribution company) to manufacture and market contrast agents (made with barium and/or iodine compounds) used for radiology digital imaging in the healthcare industry.

Website: https://voyageurpharmaceuticals.ca/


FRC Analyst's Reports

Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company Jan. 7, 2020


News

Voyageur Pharmaceuticals Ltd. Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast May. 18, 2021
Voyageur Pharmaceuticals Ltd. Issued 4th Health Canada License For Radiographic Barium Contrast Product May. 5, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals and Beneficial Ruling by the D.C. Circuit Court of Appeals Qualifying Voyageurs Products as Devices not Drugs – Video Available on Investmentpitch.com Apr. 21, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Two New License Approvals from Health Canada for its MultiX Barium Sulfate Powder Covering Oral and Rectal Applications – Video Available on Investmentpitch.com Apr. 7, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Receipt of Approval from Health Canada for Two of the Company’s Barium Contrast Products – Video Available on Investmentpitch.com Feb. 17, 2021

This company was mentioned in the following "Analysts’ Ideas Of The Week":